Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of renin-angiotensin-aldosterone system genes on the treatment response of patients with hypertension and metabolic syndrome.

Journal of the renin-angiotensin-aldosterone system : JRAAS - 1 Dec 2007

Milionis Haralampos J, Kostapanos Michael S, Vakalis Konstantinos, Theodorou Ioanna, Bouba Ioanna, Kalaitzidis Rigas, Georgiou Ioannis, Elisaf Moses S, Siamopoulos Kostas C

Abstract excerpt

OBJECTIVE: To evaluate the influence of clinical, biochemical and genetic markers on the response to antihypertensive treatment in patients with essential hypertension and the metabolic syndrome (MetS). METHODS: Measurements of anthropometric indices, blood pressure (BP), and metabolic parameters were obtained from the medical records of 132 (77 women) newly diagnosed, untreated hypertensive patients....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Demography
Share to Greece

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hypertension

Share to Metabolic Syndrome

Share to Prevalence

Share to Regression Analysis

Share to Renin-Angiotensin System

Share to Treatment Outcome

Source

Identifiers

PMID: 18205097
DOI: 10.3317/jraas.2007.027

Genes

ACE

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of renin-angiotensin-aldosterone system genes on the treatment response of patients with hypertension and metabolic syndrome.PMID 18205097Read ↗

Renin angiotensin system polymorphisms in patients with metabolic syndrome (MetS).Semantic proximity Read ↗

Association between CYP11B2 rs1799998 genetic variant with essential hypertension and antihypertensive response.Semantic proximity Read ↗

Metabolic syndrome in primary aldosteronism and essential hypertension: relationship to adiponectin gene variants.Semantic proximity Read ↗

The influence of renin-angiotensin system genotypes on the antiproteinuric response to high doses of olmesartan in non-diabetic proteinuric nephropathies.Semantic proximity Read ↗

Associations of the -344 T>C and the 3097 G>A polymorphisms of CYP11B2 gene with hypertension, type 2 diabetes, and metabolic syndrome in a French population.Semantic proximity Read ↗

Do genetic variants of the Renin-Angiotensin system predict blood pressure response to Renin-Angiotensin system-blocking drugs?: a systematic review of pharmacogenomics in the Renin-Angiotensin system.Semantic proximity Read ↗

Effect of renin-angiotensin-aldosterone system gene polymorphisms on blood pressure response to antihypertensive treatment.Semantic proximity Read ↗

Association between renin-angiotensin-aldosterone system-related genes and blood pressure in a Korean population.Semantic proximity Read ↗

Angiotensin II Type 1 Receptor Gene Polymorphism Predicts Development of Hypertension and Metabolic SyndromeSemantic proximity Read ↗

The renin-angiotensin-aldosterone system and salt sensitivity of blood pressure offer new insights in obesity phenotypes.Semantic proximity Read ↗

Genetic variant of the Renin-Angiotensin system and diabetes influences blood pressure response to Angiotensin receptor blockers.Semantic proximity Read ↗

The metabolic syndrome in hypertensive and normotensive subjects: the Isfahan Healthy Heart Programme.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.